金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301509 金凯生科

已收盘 10-31 15:00:00

{"stockData":{"symbol":"301509","market":"SZ","secType":"STK","nameCN":"金凯生科","latestPrice":38.75,"timestamp":1761894213000,"preClose":37.26,"halted":0,"volume":4979017,"delay":0,"changeRate":0.04,"floatShares":56740900,"shares":120000000,"eps":0.8531,"marketStatus":"已收盘","change":1.49,"latestTime":"10-31 15:00:00","open":37.26,"high":38.97,"low":37.26,"amount":192000000,"amplitude":0.0459,"askPrice":38.76,"askSize":429,"bidPrice":38.75,"bidSize":19,"shortable":0,"etf":0,"ttmEps":0.8531,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":37.26,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":40.99,"lowLimit":33.53,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120446669,"isCdr":false,"pbRate":2.04,"roa":"--","peRate":45.422576,"roe":"4.74%","epsLYR":0.32,"committee":-0.908762,"marketValue":4667000000,"turnoverRate":0.0878,"status":0,"floatMarketCap":2199000000},"requestUrl":"/m/hq/s/301509","defaultTab":"news","newsList":[{"id":"2578366882","title":"股市必读：金凯生科(301509)股东户数1.38万户，较上期减少1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578366882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578366882?lang=zh_cn&edition=full","pubTime":"2025-10-27 05:57","pubTimestamp":1761515832,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，金凯生科报收于36.45元，上涨2.24%，换手率3.42%，成交量1.94万手，成交额7029.99万元。来自股本股东变化：截至2025年10月20日，公司股东户数环比下降1.35%，户均持股上升至8740.0股，筹码集中度有所提升。股本股东变化股东户数变动近日金凯生科披露，截至2025年10月20日公司股东户数为1.38万户，较10月10日减少188.0户，减幅为1.35%。户均持股数量由上期的8622.0股增加至8740.0股，户均持股市值为31.74万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2578834386","title":"金凯生科（301509）2025年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578834386","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578834386?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:17","pubTimestamp":1761430634,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金凯生科发布2025年三季报。截至本报告期末，公司营业总收入4.88亿元，同比上升25.96%，归母净利润1.03亿元，同比上升163.24%。按单季度数据看，第三季度营业总收入1.39亿元，同比上升11.27%，第三季度归母净利润3166.87万元，同比上升339.92%。本报告期金凯生科应收账款上升，应收账款同比增幅达62.62%。去年的净利率为7.77%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600002348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"gpt_icon":0},{"id":"2577374384","title":"金凯生科(301509)10月20日股东户数1.38万户，较上期减少1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577374384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577374384?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:16","pubTimestamp":1761210998,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年10月20日公司股东户数为1.38万户，较10月10日减少188.0户，减幅为1.35%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至10月20日，医疗服务行业平均股东户数为4.45万户。从股价来看，2025年10月10日至2025年10月20日，金凯生科区间跌幅为1.12%，在此期间股东户数减少188.0户，减幅为1.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300026491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2577384743","title":"金凯生科：截至2025年10月20日股东数为13,781户","url":"https://stock-news.laohu8.com/highlight/detail?id=2577384743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577384743?lang=zh_cn&edition=full","pubTime":"2025-10-22 08:54","pubTimestamp":1761094447,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止到10月20日收盘，公司股东人数有多少？金凯生科回复：尊敬的投资者，您好！截至2025年10月20日，公司股东数为13,781户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200006855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2575417917","title":"股市必读：金凯生科(301509)股东户数1.41万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575417917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575417917?lang=zh_cn&edition=full","pubTime":"2025-10-13 04:19","pubTimestamp":1760300351,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，金凯生科报收于36.72元，下跌0.49%，换手率3.07%，成交量1.74万手，成交额6411.37万元。股本股东变化股东户数变动截至2025年9月30日，金凯生科股东户数为1.41万户，较9月19日减少211.0户，减幅1.48%；户均持股数量升至8550.0股，户均持股市值为31.43万元。董秘最新回复投资者： 请问9月30日的股东户数是多少？截至2025年9月30日，公司股东数为14,088户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2574114335","title":"金凯生科：截至2025年9月30日股东数为14,088户","url":"https://stock-news.laohu8.com/highlight/detail?id=2574114335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574114335?lang=zh_cn&edition=full","pubTime":"2025-10-10 11:36","pubTimestamp":1760067385,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，你好!请问截止至2025年9月30日，公司股东人数总数是多少?谢谢!金凯生科回复：尊敬的投资者，您好！截至2025年9月30日，公司股东数为14,088户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000014335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2570089065","title":"股市必读：金凯生科(301509)股东户数1.43万户，较上期减少3.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570089065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570089065?lang=zh_cn&edition=full","pubTime":"2025-09-25 01:08","pubTimestamp":1758733700,"startTime":"0","endTime":"0","summary":"截至2025年9月24日收盘，金凯生科报收于36.17元，上涨1.46%，换手率3.77%，成交量2.14万手，成交额7706.76万元。当日关注点来自交易信息汇总：9月24日主力资金净流出439.93万元，散户资金净流入588.58万元。股本股东变化股东户数变动近日金凯生科披露，截至2025年9月19日公司股东户数为1.43万户，较9月10日减少541.0户，减幅为3.65%。户均持股数量由上期的8116.0股增加至8423.0股，户均持股市值为31.17万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500000549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2569549467","title":"金凯生科：截至2025年9月19日股东数为14,299户","url":"https://stock-news.laohu8.com/highlight/detail?id=2569549467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569549467?lang=zh_cn&edition=full","pubTime":"2025-09-23 08:58","pubTimestamp":1758589097,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止9月20日公司股东人数是多少？谢谢金凯生科回复：尊敬的投资者，您好！截至2025年9月19日，公司股东数为14,299户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300005882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2566595037","title":"金凯生科：截至2025年9月10日股东数为14,840户","url":"https://stock-news.laohu8.com/highlight/detail?id=2566595037","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566595037?lang=zh_cn&edition=full","pubTime":"2025-09-11 16:27","pubTimestamp":1757579237,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问9月10日的股东户数是多少个？金凯生科回复：尊敬的投资者，您好！截至2025年9月10日，公司股东数为14,840户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100026012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2565689939","title":"9月8日金凯生科发布公告，股东减持316.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565689939","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565689939?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:01","pubTimestamp":1757332906,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日金凯生科发布公告《金凯生科:关于股东减持股份计划期间届满暨减持结果的公告》，其股东蓝色经济区产业投资基金(有限合伙)于2025年5月22日至2025年9月1日间合计减持316.84万股，占公司目前总股本的2.6305%，变动期间该股股价上涨12.99%，截止9月1日收盘报41.05元。股东增减持详情见下表：根据金凯生科2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800029677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2564870893","title":"金凯生科：截至2025年8月29日股东数为15,356户","url":"https://stock-news.laohu8.com/highlight/detail?id=2564870893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564870893?lang=zh_cn&edition=full","pubTime":"2025-09-02 17:03","pubTimestamp":1756803787,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问8月30日的股东户数是多少个？金凯生科回复：尊敬的投资者，您好！截至2025年8月29日，公司股东数为15,356户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200027825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2564779728","title":"金凯生科：小分子化药CDMO订单量丰厚","url":"https://stock-news.laohu8.com/highlight/detail?id=2564779728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564779728?lang=zh_cn&edition=full","pubTime":"2025-09-02 16:57","pubTimestamp":1756803432,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科09月02日在投资者关系平台上答复投资者关心的问题。因此小分子药制造企业的未来发展前途会比较受限制？感谢您对公司的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200027629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2562271376","title":"金凯生科：掌握氟化反应等多种技术能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2562271376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562271376?lang=zh_cn&edition=full","pubTime":"2025-08-27 16:21","pubTimestamp":1756282872,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科08月27日在投资者关系平台上答复投资者关心的问题。公司掌握包括氟化反应、氯化反应、光气化反应、硼酸化反应、低温反应、手性合成等多种技术能力，其中在氟化领域，公司的氟化氢氟化、氟化钾氟化、四氟化硫氟化、特殊氟化剂氟化以及电解氟化等特色工艺技术，能够为客户在含氟药物领域提供高效率、高质量、低成本、安全环保的中间体或原料药定制研发、生产服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700033549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2562649267","title":"股市必读：金凯生科中报 - 第二季度单季净利润同比增长58.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562649267","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562649267?lang=zh_cn&edition=full","pubTime":"2025-08-25 06:22","pubTimestamp":1756074137,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，金凯生科报收于44.04元，上涨0.39%，换手率15.75%，成交量8.94万手，成交额3.95亿元。业绩披露要点：金凯生科2025年中报显示，公司主营收入3.48亿元，同比上升32.98%；归母净利润7176.06万元，同比上升123.61%。股本股东变化近日，金凯生科披露了最新的股东户数变动情况：- 截至2025年8月20日，公司股东户数为1.41万户，较8月8日增加417户，增幅为3.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500001249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"gpt_icon":0},{"id":"2561253465","title":"金凯生科（301509）2025年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2561253465","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561253465?lang=zh_cn&edition=full","pubTime":"2025-08-24 06:19","pubTimestamp":1755987544,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金凯生科发布2025年中报。截至本报告期末，公司营业总收入3.48亿元，同比上升32.98%，归母净利润7176.06万元，同比上升123.61%。按单季度数据看，第二季度营业总收入1.72亿元，同比上升24.99%，第二季度归母净利润2434.28万元，同比上升58.58%。本报告期金凯生科盈利能力上升，毛利率同比增幅9.7%，净利率同比增幅68.15%。所得税费用变动幅度为388.62%,原因:当期利润总额增加。筹资活动产生的现金流量净额变动幅度为35.76%,原因:当期支付股利减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400001810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"gpt_icon":0},{"id":"2561420099","title":"金凯生科(301509)8月20日股东户数1.41万户，较上期增加3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561420099","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561420099?lang=zh_cn&edition=full","pubTime":"2025-08-22 17:47","pubTimestamp":1755856025,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年8月20日公司股东户数为1.41万户，较8月8日增加417.0户，增幅为3.04%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至8月20日，医疗服务行业平均股东户数为4.49万户。从股价来看，2025年8月8日至2025年8月20日，金凯生科区间涨幅为12.54%，在此期间股东户数增加417.0户，增幅为3.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200033329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2561422701","title":"金凯生科(301509.SZ)发布上半年业绩，归母净利润7176.06万元，增长123.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561422701","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561422701?lang=zh_cn&edition=full","pubTime":"2025-08-22 17:09","pubTimestamp":1755853758,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金凯生科(301509.SZ)发布2025年半年度报告，该公司营业收入为3.48亿元，同比增长32.98%。归属于上市公司股东的净利润为7176.06万元，同比增长123.61%。归属于上市公司股东的扣除非经常性损益的净利润为5917.48万元，同比增长141.51%。基本每股收益为0.6元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"金凯生科(301509.SZ)发布上半年业绩，归母净利润7176.06万元，增长123.61%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301509"],"gpt_icon":0},{"id":"2561452834","title":"金凯生科：公司目前暂未有收到股东的减持计划告知函","url":"https://stock-news.laohu8.com/highlight/detail?id=2561452834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561452834?lang=zh_cn&edition=full","pubTime":"2025-08-21 15:51","pubTimestamp":1755762665,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)08月20日在投资者关系平台上答复投资者关心的问题。投资者提问：近期公司是否还有减持计划金凯生科回复：尊敬的投资者，您好！公司目前暂未有收到股东的减持计划告知函。如有股东依据监管规则及其相关承诺向公司发出减持计划，公司将按信披规则等要求进行信息披露。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100023272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2560827167","title":"金凯生科8月19日现1笔大宗交易 总成交金额1751.6万元 其中机构买入1751.6万元 溢价率为-1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560827167","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560827167?lang=zh_cn&edition=full","pubTime":"2025-08-19 17:41","pubTimestamp":1755596460,"startTime":"0","endTime":"0","summary":"　　8月19日，金凯生科收涨6.49%，收盘价为44.46元，发生1笔大宗交易，合计成交量40万股，成交金额1751.6万元。　　第1笔成交价格为43.79元，成交40.00万股，成交金额1,751.60万元，溢价率为-1.51%，买方营业部为机构专用，卖方营业部为中信证券(山东)有限责任公司青岛秦岭路证券营业部。　　进一步统计，近3个月内该股累计发生18笔大宗交易，合计成交金额为9641.57万元。该股近5个交易日累计上涨15.60%，主力资金合计净流出1231.71万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-08-19/doc-infmpiyz2544032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2560908407","title":"8月18日金凯生科现1644.8万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2560908407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560908407?lang=zh_cn&edition=full","pubTime":"2025-08-18 17:31","pubTimestamp":1755509478,"startTime":"0","endTime":"0","summary":"证券之星消息，8月18日金凯生科发生大宗交易，交易数据如下：近三个月该股共发生17笔大宗交易，合计成交2.01万手，折价成交17笔。该股近期无解禁股上市。截至2025年8月18日收盘，金凯生科(301509)报收于41.75元，上涨10.71%，换手率24.86%，成交量14.11万手，成交额5.82亿元。该股近半年内有股东持股变动，合计净减持527.63万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800024203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761970054052,"stockEarnings":[{"period":"1week","weight":0.0631},{"period":"1month","weight":0.0541},{"period":"3month","weight":-0.0244},{"period":"6month","weight":0.3085},{"period":"1year","weight":0.2703},{"period":"ytd","weight":0.5133}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.1109},{"period":"6month","weight":0.2061},{"period":"1year","weight":0.2058},{"period":"ytd","weight":0.1799}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金凯(辽宁)生命科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"13781人(较上一季度减少1.35%)","perCapita":"4117股","listingDate":"2023-08-03","address":"辽宁省阜新市阜新蒙古族自治县伊吗图镇氟化工园区安仁路6号","registeredCapital":"12044万元","survey":"　　金凯(辽宁)生命科技股份有限公司的主营业务是为全球原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司的主要产品是三氟甲氧基或三氟甲基的苯类中间体、氟代芳环类中间体、含氮杂环系列、氨的脂肪族有机衍生物、羧酸及其衍生物、烯烃类、非氟卤代苯类、酚类、酮类、异氰酸酯类。","listedPrice":56.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金凯生科,301509,金凯生科股票,金凯生科股票老虎,金凯生科股票老虎国际,金凯生科行情,金凯生科股票行情,金凯生科股价,金凯生科股市,金凯生科股票价格,金凯生科股票交易,金凯生科股票购买,金凯生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}